{
    "root": "60c69cc4-203a-4d95-a834-ca6a7eb3ab8b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE",
    "value": "20240115",
    "ingredients": [],
    "indications": {
        "text": "norethindrone ethinyl estradiol tablets ( chewable ) 0.8 mg/0.025 mg ferrous fumarate tablets ( chewable ) 75 mg indicated women prevent pregnancy . efficacy norethindrone ethinyl estradiol tablets ( chewable ) 0.8 mg/0.025 mg ferrous fumarate tablets ( chewable ) 75 mg women body mass index ( bmi ) > 35 kg/m2 evaluated .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 chew one tablet without water time every day . ( 2.1 ) \u2022 take tablets order directed blister pack . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "norethindrone ethinyl estradiol tablets ( chewable ) ferrous fumarate tablets ( chewable ) contraindicated females known develop following conditions : \u2022a high risk arterial venous thrombotic diseases . examples include women known : osmoke , age 35 [ boxed warning , ( 5.1 ) ] ohave deep vein thrombosis pulmonary embolism , past [ ( 5.1 ) ] ohave cerebrovascular disease [ ( 5.1 ) ] ohave coronary artery disease [ ( 5.1 ) ] ohave thrombogenic valvular thrombogenic rhythm diseases heart ( example , subacute bacterial endocarditis valvular disease , atrial fibrillation ) [ ( 5.1 ) ] ohave inherited acquired hypercoagulopathies [ ( 5.1 ) ] ohave uncontrolled hypertension [ ( 5.5 ) ] ohave diabetes vascular disease [ ( 5.7 ) ] ohave headaches focal neurological symptoms migraine headaches without aura age 35 [ ( 5.8 ) ] \u2022current diagnosis , history , breast cancer , may hormone-sensitive [ ( 5.2 ) ] \u2022liver tumors , benign malignant , liver disease [ ( 5.3 ) , ( 8.7 ) , pharmacology ( 12.3 ) ] \u2022undiagnosed abnormal uterine bleeding [ ( 5.9 ) ] \u2022pregnancy , reason cocs pregnancy [ ( 5.9 ) ( 8.1 ) ] \u2022use hepatitis c combinations containing ombitasvir/paritaprevir/ritonavir , without dasabuvir , due potential alt elevations [ ( 5.4 ) ]",
    "indications_original": "Norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets (chewable) 75 mg are indicated for use by women to prevent pregnancy. \n                  The efficacy of norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets (chewable) 75 mg in women with a body mass index (BMI) of > 35 kg/m2 has not been evaluated.",
    "contraindications_original": "\u2022 Chew one tablet without water at the same time every day. ( 2.1 ) \u2022 Take tablets in the order directed on the blister pack. ( 2.1 )",
    "adverseReactions_original": "Norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) are contraindicated in females who are known to have or develop the following conditions: \n                  \n                     \n                        \u2022A high risk of arterial or venous thrombotic diseases. Examples include women who are known to:s\n                           \n                              oSmoke, if over age 35 [see Boxed Warning, and Warnings and Precautions (5.1)] \n                           \n                           \n                              oHave deep vein thrombosis or pulmonary embolism, now or in the past [see Warnings and Precautions (5.1)] \n                           \n                           \n                              oHave cerebrovascular disease [see Warnings and Precautions (5.1)] \n                           \n                           \n                              oHave coronary artery disease [see Warnings and Precautions (5.1)] \n                           \n                           \n                              oHave thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings and Precautions (5.1)]\n                           \n                           \n                              oHave inherited or acquired hypercoagulopathies [see Warnings and Precautions (5.1)] \n                           \n                           \n                              oHave uncontrolled hypertension [see Warnings and Precautions (5.5)] \n                           \n                           \n                              oHave diabetes with vascular disease [see Warnings and Precautions (5.7)] \n                           \n                           \n                              oHave headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35 [see Warnings and Precautions (5.8)] \n                           \n                        \n                     \n                     \n                        \u2022Current diagnosis of, or history of, breast cancer, which may be hormone-sensitive [see Warnings and Precautions (5.2)] \n                     \n                     \n                        \u2022Liver tumors, benign or malignant, or liver disease [see Warnings and Precautions (5.3), Use in Specific Populations (8.7), and Clinical Pharmacology (12.3)] \n                     \n                     \n                        \u2022Undiagnosed abnormal uterine bleeding [see Warnings and Precautions (5.9)] \n                     \n                     \n                        \u2022Pregnancy, because there is no reason to use COCs during pregnancy [see Warnings and Precautions (5.9) and Use in Specific Populations (8.1)] \n                     \n                     \n                        \u2022Use of Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations [see Warnings and Precautions (5.4)]",
    "drug": [
        {
            "name": "NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_23965"
        }
    ]
}